Isolated Form of Left Ventricular Non-compaction Cardiomyopathy (LVNC) as a Rare Cause of Heart Failure by Sotiris, Skopoulis
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Isolated Form of Left Ventricular Non-compaction
Cardiomyopathy (LVNC) as a Rare Cause of Heart
Failure
Skopoulis Sotiris
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.76379
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
li   i i
dditional infor ation is available at the end of the chapter
Abstract
Non-compaction cardiomyopathy (LVNC) is a rare, hereditary disease manifested by 
heart failure, thromboembolic complications and arrhythmias, which can even result in 
a sudden cardiac arrest. This disease is often misdiagnosed as dilated or ischemic car-
diomyopathy, apical hypertrophic cardiomyopathy, or other myocardial infiltrative pro-
cesses, including tumours. Due to its potentially severe complications and outcomes it 
should be always considered as a part of differential diagnosis.
Keywords: non-compaction cardiomyopathy, heart failure, trabecularisation, 
echocardiography, cardiomyopathy
1. Introduction
Non-compaction cardiomyopathy (LVNC) is a rare, hereditary disease. It is believed that 
develops due to a defect during embryogenesis of endocardium and myocardium. In 1996 
LVNC was categorised as non-classified cardiomyopathy according to the WHO classification 
of cardiomyopathy.
A typical image of LVNC is thickening of the apical wall in the left ventricle due to increased 
trabecularisation and occurrence of deep inter-trabecular recesses communicating with the left 
ventricle. Dilation and/or systolic dysfunction of the left ventricle (LV) is usually present [1].
The disease may manifest as an isolated myocardial disorder (an isolated form of LVNC) 
or in relation with congenital heart defects, such as pulmonary atresia, defects in the atrial 
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and ventricular septum, obstructions of the outflow tract of the left or right ventricle or 
Ebstein’s anomaly.
2. Prevalence
The actual LVNC prevalence value is difficult to determine, because the frequency of its occur-
rence significantly differs in relation to the studied population.
Based on 14-year reviewing of results of echocardiographic examinations of patients, one of 
the available studies described 34 patients with LVNC in total, which represented prevalence 
of 0.014%. A different clinical study diagnosed in the course of 4.5 years 57 patients with 
LVNC with use of echocardiographic criteria and prevalence reached 0.14% [2, 3].
The normal value of prevalence according to other studies ranges between 0.05 and 0.24% [3, 4].
In children with LVNC it represents the third most frequent cardiomyopathy and approxi-
mately 9% of all cardiomyopathies [5].
The age of clinical manifestation of the disease symptoms is very variable—at least two cases 
were described in the bibliography where the diagnosis was already established in utero [6]. 
The oldest patient with LVNC was aged 94 when diagnosed [7, 8].
3. Genetics
It is not easy to explain the genetic base for the phenotype expression of LVNC, because cases 
of both hereditary and also sporadic forms of this disease have been described. It seems that 
their occurrence in childhood is related to a pronounced genetic base, which cannot be said 
with certainty, as concerns its occurrence in adulthood. The genes associated with the occur-
rence of LVNC include tafazzin, beta-dystrobrevin (DTNA), Cypher/ZASP (LDB3), lamin A/C 
(LMNA), SCN5A, MYH7, and MYBPC3 [9–12].
Although it is obvious that further extensive investigation is needed to describe the genetic 
base of this disease in detail, we may already conclude with certainty that a certain genetic 
heterogeneity is needed.
The percentage of cases of hereditary forms of LVNC in three large groups of patients reached 
18, 25, and 33% [8, 13, 14].
Heredity of this disease is usually autosomal and dominant with incomplete penetration. 
LVNC with a defective gene for G4.5 that causes gonosomal hereditary Barth syndrome (dila-
tion cardiomyopathy or LVNC in men with symptoms from childhood accompanied with 
neutropenia, lactic acidosis and abnormalities in lipid metabolism is an exception [15, 16].
Even though routine genetic testing of patients has not been currently recommended, accord-
ing to the procedures advised by HFSA (Heart Failure Society of America) detail investigation 
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of the history of at least three family generations and cardiological examination of the patient’s 
direct relatives with established LVNC is clearly recommended with regard to its prevailing 
occurrence in the family [17].
The benefits of screening genetic testing of all direct relatives of the patient with LVNC must 
also be considered in the future.
4. Embryology, histology
In the course of embryogenesis before development of coronary veins myocardium is made 
of a free network of intertwined trabeculae and deep recesses. Coronary vessels develop 
between the 5th and 8th week of intrauterine life and gradual connection of myocardial tra-
beculae occurs under regular conditions until the compact myocardial layer starts to prevail 
over the spongeous layer [9]. This process runs quite fast between the 10th and 12th week of 
the embryonic development and proceeds from the left ventricular base towards the apex and 
from epicardium to endocardium, while the left ventricular myocardium is more compact 
then the right ventricular myocardium, which stays more trabecularised also in adulthood.
It is currently anticipated that LVNC occurs due to a disordered myocardium compaction 
in the course of embryogenesis that is most frequently caused due to mutation of sarcomere 
proteins, which leads in excessive myocardial trabecularisation that is usually localised on the 
apex of left ventricle and apical segments of the lateral and inferior wall [10, 11].
Anatomic criteria for determination of the LVNC diagnosis according to Burke et al. include: (1) 
absence of normally formed papillary muscles in the left ventricle, (2) the proportion of the over-
all thickness of the left ventricular wall and the layer of compact myocardium exceeds two [18].
The histochemical image is usually dominated with endocardial thickening, endocardial 
fibrosis to endocardial fibroelastosis, deep intertrabecular recesses and focuses of interstitial 
fibrosis or even microinfarctions.
5. Clinical manifestation and treatment of the disease
The onset of clinical manifestation of the symptoms in patients with an isolated form of LVNC 
is variable; many patients remain asymptomatic for years, while some individuals show 
development of the symptoms since early childhood [19].
In asymptomatic patients, the diagnosis is established during a preventive echocardiographic 
examination or as consequence of targeted screening due to a positive family history.
The main clinical manifestation of LVNC is left-sided heart failure that most frequently mani-
fests with dyspnoea, stenocardia, palpitation or syncope. Other manifestations of the disease 
include ventricular arrhythmias and subsequent sudden cardiac death. Thromboembolic 
complications are frequent.
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Men are affected more frequently than women [8].
Standard cardiac failure treatment procedures are applied in the case of left ventricular heart 
insufficiency, mainly beta-blockers, ACE inhibitors and diuretics. Aldosterone inhibitors, 
digoxin and vasodilators can also be used in the therapy.
Upon occurrence of ventricular arrhythmia, specifically non-sustained ventricular tachycar-
dia, without significant LV dysfunction, treatment with beta-blockers or amiodarone is indi-
cated. ICD implantation should be considered in patients with obvious sustained ventricular 
tachycardia, inexplicable syncope or in patients with left ventricular EF under 35% persisting 
despite adequate therapy, as a primary prevention of sudden cardiac death.
Benefit of resynchronisation therapy has been described in a group of patients with LVNC [20].
Stollberger et al. describe improvement of the systolic function in the left ventricle in the 
course regular control echocardiography (reduced creation of trabecularisation and improve-
ment in the myocardial compaction) in a number of patients with LVNC after bi-ventricular 
pacing (follow up programme for the period of 4–68 months) [21].
In the case of patients with end stage heart failure despite adequate pharmacotherapy, the use 
of mechanical heart support or enlisting in a transplantation programme must be considered. 
Patients with dilation and significant left ventricular dysfunction are advised to use perma-
nent anticoagulation treatment as a prevention of embolic complications [1, 8].
6. Diagnostics
The currently used diagnostic standard comprises a proper obtainment of family history for the 
last three generations, an echocardiographic examination and magnetic resonance of the heart.
In most of the patients ECG is manifested with non-specific changes of repolarization, bundle 
branch blocks and various degrees of AV blocks [1].
However, the basic diagnostic method for LVNC is echocardiography. A typical echocardio-
graphic examination of LVNC describes a “layered” picture of myocardium made of a thin 
outer compact layer and a strong trabecularised non-compact endocardial layer with frequent 
deep intertrabecular recesses that are usually localised in the apical area under the level of 
papillary muscles and adjacent segments of the lateral and inferior walls [22–24].
In 2001, Jenni et al. proposed criteria based on an end systolic ratio of non-compacted to 
compacted layers above two. Segments involved are mid ventricular (especially inferior and 
lateral ones) and apical [25, 26].
A number of authors believe that the current diagnostic criteria have an excessively high sen-
sitiveness, which may cause overestimation of the LVNC prevalence [19].
Finsterer and Stollberger [27] proposed fusion of diagnostic criteria according to Jenni and 
Stollberger with subsequent classification in the following categories:
1. LVNC diagnosis is possible;
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2. LVNC diagnosis is probable;
3. LVNC diagnosis is definitive.
according to the number of shown characteristics.
In 2008 Belanger et al. proposed a new scheme classifying LVNC as a non-probable, moderate, 
rather significant and serious disease on the basis of the numerical value of the NC/C Index 
(ratio of the non-compact layer to the compact layer) of 0, 1, 2 and more than 2. Another crite-
rion should include the size of the area suffering from non-compaction [28].
3D echocardiography or magnetic resonance of the heart (CMR) are methods that may be used 
if the patient is not easily examinable upon a regular echocardiographic examination, mainly 
due to inability to visualise the apex of the heart. The criterion to determine the LVNC diagnosis 
comprises the ratio of non-compact myocardial layer (NC/C Index or NC/C Ratio) exceeding 
2.3 during diastole, which distinguishes pathological non-compaction with sensitivity values 
of 86%, specificity of 99%, positive prediction of 75% and negative prediction of 75% [29].
Computer tomography (CT and CT angiography) is used less frequently in LVNC diagnostics; 
it enables displaying of coronary vessels and also the associated congenital anomalies (e.g. 
stenosis or pulmonary atresia).
Contrast left-sided ventriculography shows typical deep recessions and spongeous appear-
ance of the cavity [16].
7. Prognosis
Prognosis for the patients with LVNC differs; almost 60% of the patients described in one of 
the multicentral studies either died or underwent a heart transplantation within 6 years from 
establishment of the diagnose [4].
Mortality in the subsequent series of adult patients with LVNC reached 35% during 44 months 
of monitoring and half of them died suddenly [13].
8. Case report
Case of a patient aged 39 that has not been treated so far and was examined at an acute cardi-
ological outpatient office of the district hospital for exertional dyspnoea lasting for already 2 
months, functionally according to NYHA (New York Heart Association) classified in grade 3 
and oedemas on lower limbs lasting for 3 years. Physical examination showed blood pressure 
(170/110 mmHg), hepatomegaly and bilateral perimalleolar oedemas. ECG at the admission 
also described a mild sinus tachycardia, P pulmonale in leads II, III, and aVF, descendent depres-
sion of ST sections with a negative T wave in leads II, III, and aVF. Laboratory examination 
revealed only a slight elevation of cardiac markers without dynamic change correspond-
ing to an acute coronary syndrome, an elevation of natriuretic peptide type B, and a slight 
elevation of liver enzymes. In the course of hospitalisation was performed transthoracic 
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echocardiography examination (Pictures 1 and 2) and transesophageal echocardiographic 
examination (Picture 3). Both showed severe systolic dysfunction of the remodelled LV with 
EF of 20%, global hypokinesis, trabecularisation of the left ventricle, a mobile thrombus in LV 
and severe systolic dysfunction of dilated RV.
Coronary angiography only showed non-significant atherosclerosis of the coronary vessels.
Magnetic heart resonance was carried out electively and confirmed echocardiographic examina-
tion findings. The examination confirmed severe systolic LV dysfunction with EF of 16%, signifi-
cant global LV hypokinesia, visible LV trabecularisation, a fluttering thrombus between trabeculae 
in the central LV segment, dilation of the left atrium and right-sided chambers (Picture 4).
Heart failure therapy was immediately initiated. Anticoagulation therapy was added. It led 
to a prompt improvement of the clinical condition. Despite the adequate therapy an improve-
ment of the systolic function of the left ventricle was not observed. The patient was referred 
as a candidate of ICD implantation for primary prevention of sudden cardiac death and was 
also enlisted as a candidate for heart transplantation.
Picture 1. 2D echocardiography: apical four-cavity projection. Significant trabecularisation of spherically remodelled left 
ventricle in different projections.
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Picture 2. 2D echocardiography from parasternal short axis. Significant trabecularisation of spherically remodelled left 
ventricle in different projections.
Picture 3. Transesophageal echocardiography with a typical finding of trabecularised dysfunctional LV and dilation of 
the left atrium.




Occurrence of LVNC is rare, nevertheless due to its potentially severe complications and out-
comes it should be always considered as a part of differential diagnosis.
The goal for the future is to collect as much data as possible concerning the clinical course of 
the disease, its genetic background, diagnostics, and treatment. This strategy may positively 
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